- Report
- October 2024
- 199 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 276 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 89 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 171 Pages
Global
From €5205EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- May 2024
- 184 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Clinical Trials
- December 2024
- 240 Pages
Global
From €2865EUR$3,000USD£2,396GBP
- Report
- July 2024
- 150 Pages
Global
From €3581EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3581EUR$3,750USD£2,995GBP
- Report
- January 2025
- 185 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- January 2024
- 157 Pages
Global
From €4441EUR$4,650USD£3,714GBP
- Report
- December 2022
- 196 Pages
United States
From €2507EUR$2,625USD£2,096GBP
€5014EUR$5,250USD£4,193GBP
- Report
- December 2022
- 223 Pages
Global
From €2507EUR$2,625USD£2,096GBP
€5014EUR$5,250USD£4,193GBP
- Report
- November 2023
- 250 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- December 2024
- 82 Pages
India
From €3343EUR$3,500USD£2,795GBP
- Report
- July 2024
- 82 Pages
India
From €3343EUR$3,500USD£2,795GBP
- Report
- July 2023
- 78 Pages
United States
From €3343EUR$3,500USD£2,795GBP
- Report
- November 2023
- 230 Pages
Global
From €7163EUR$7,500USD£5,990GBP
- Report
- February 2024
- 117 Pages
Global
From €4536EUR$4,750USD£3,794GBP

The Prostate Specific Antigen (PSA) market is a segment of the Diagnostics industry that focuses on the detection of prostate cancer. PSA tests measure the amount of PSA in a patient's blood, which can be an indicator of prostate cancer. PSA tests are typically used in conjunction with other tests, such as digital rectal exams, to diagnose prostate cancer. PSA tests are also used to monitor the progression of prostate cancer in patients who have already been diagnosed.
The PSA market is highly competitive, with a number of companies offering PSA tests. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Other companies in the market include Becton Dickinson, Ortho Clinical Diagnostics, and Sysmex Corporation. Show Less Read more